# Effect Observation Study of COX-2 Inhibitor to Treat Primary Hypertrophic Osteoarthropathy

> **NCT02438709** · PHASE3 · UNKNOWN · sponsor: **Peking Union Medical College Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Primary Hypertrophic Osteoarthropathy

## Interventions

- **DRUG:** COX-2 inhibitor

## Key facts

- **NCT ID:** NCT02438709
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-12
- **Primary completion:** 2015-07
- **Final completion:** 2016-07
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2015-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02438709

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02438709, "Effect Observation Study of COX-2 Inhibitor to Treat Primary Hypertrophic Osteoarthropathy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02438709. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*